- call +1-201-465-4211
- email sales@mrinsights.biz
An antifungal medication, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others.
Scope of the Report:
This report focuses on the Antifungal Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Antifungal Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Asperqillus
Alternaria
Abbott Laboratories
Pfizer
Glaxosmithkline
Bayer Healthcare
Novartis
Sanofi-Aventis
Merck & Co.
Kramer Laboratories
Enzon Pharmaceuticals
Gilead
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Echinocandins
Azoles
Ployenes
Allylamines
Market Segment by Applications, can be divided into
Aspergillosis
Dermatophytosis
Candidiasis
There are 15 Chapters to deeply display the global Antifungal Drug market.
Chapter 1, to describe Antifungal Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antifungal Drug, with sales, revenue, and price of Antifungal Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Antifungal Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Antifungal Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Antifungal Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Antifungal Drug Introduction
1.2 Market Analysis by Type
1.2.1 Echinocandins
1.2.2 Azoles
1.2.3 Ployenes
1.2.4 Allylamines
1.3 Market Analysis by Applications
1.3.1 Aspergillosis
1.3.2 Dermatophytosis
1.3.3 Candidiasis
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Asperqillus
2.1.1 Business Overview
2.1.2 Antifungal Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Asperqillus Antifungal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Alternaria
2.2.1 Business Overview
2.2.2 Antifungal Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Alternaria Antifungal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Abbott Laboratories
2.3.1 Business Overview
2.3.2 Antifungal Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abbott Laboratories Antifungal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Antifungal Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Antifungal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Glaxosmithkline
2.5.1 Business Overview
2.5.2 Antifungal Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Glaxosmithkline Antifungal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bayer Healthcare
2.6.1 Business Overview
2.6.2 Antifungal Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Healthcare Antifungal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Antifungal Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis Antifungal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sanofi-Aventis
2.8.1 Business Overview
2.8.2 Antifungal Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sanofi-Aventis Antifungal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Merck & Co.
2.9.1 Business Overview
2.9.2 Antifungal Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Merck & Co. Antifungal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Kramer Laboratories
2.10.1 Business Overview
2.10.2 Antifungal Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Kramer Laboratories Antifungal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Enzon Pharmaceuticals
2.11.1 Business Overview
2.11.2 Antifungal Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Enzon Pharmaceuticals Antifungal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Gilead
2.12.1 Business Overview
2.12.2 Antifungal Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Gilead Antifungal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Antifungal Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Antifungal Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antifungal Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Antifungal Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Antifungal Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Antifungal Drug Market Analysis by Regions
4.1 Global Antifungal Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Antifungal Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Antifungal Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Antifungal Drug Sales and Growth Rate (2013-2018)
4.3 Europe Antifungal Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Antifungal Drug Sales and Growth Rate (2013-2018)
4.5 South America Antifungal Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Antifungal Drug Sales and Growth Rate (2013-2018)
5 North America Antifungal Drug by Countries
5.1 North America Antifungal Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Antifungal Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Antifungal Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Antifungal Drug Sales and Growth Rate (2013-2018)
5.3 Canada Antifungal Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Antifungal Drug Sales and Growth Rate (2013-2018)
6 Europe Antifungal Drug by Countries
6.1 Europe Antifungal Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Antifungal Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Antifungal Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Antifungal Drug Sales and Growth Rate (2013-2018)
6.3 UK Antifungal Drug Sales and Growth Rate (2013-2018)
6.4 France Antifungal Drug Sales and Growth Rate (2013-2018)
6.5 Russia Antifungal Drug Sales and Growth Rate (2013-2018)
6.6 Italy Antifungal Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Antifungal Drug by Countries
7.1 Asia-Pacific Antifungal Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Antifungal Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Antifungal Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Antifungal Drug Sales and Growth Rate (2013-2018)
7.3 Japan Antifungal Drug Sales and Growth Rate (2013-2018)
7.4 Korea Antifungal Drug Sales and Growth Rate (2013-2018)
7.5 India Antifungal Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Antifungal Drug Sales and Growth Rate (2013-2018)
8 South America Antifungal Drug by Countries
8.1 South America Antifungal Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Antifungal Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Antifungal Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Antifungal Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Antifungal Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Antifungal Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Antifungal Drug by Countries
9.1 Middle East and Africa Antifungal Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antifungal Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Antifungal Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Antifungal Drug Sales and Growth Rate (2013-2018)
9.3 UAE Antifungal Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Antifungal Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Antifungal Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Antifungal Drug Sales and Growth Rate (2013-2018)
10 Global Antifungal Drug Market Segment by Type
10.1 Global Antifungal Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Antifungal Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Antifungal Drug Revenue and Market Share by Type (2013-2018)
10.2 Echinocandins Sales Growth and Price
10.2.1 Global Echinocandins Sales Growth (2013-2018)
10.2.2 Global Echinocandins Price (2013-2018)
10.3 Azoles Sales Growth and Price
10.3.1 Global Azoles Sales Growth (2013-2018)
10.3.2 Global Azoles Price (2013-2018)
10.4 Ployenes Sales Growth and Price
10.4.1 Global Ployenes Sales Growth (2013-2018)
10.4.2 Global Ployenes Price (2013-2018)
10.5 Allylamines Sales Growth and Price
10.5.1 Global Allylamines Sales Growth (2013-2018)
10.5.2 Global Allylamines Price (2013-2018)
11 Global Antifungal Drug Market Segment by Application
11.1 Global Antifungal Drug Sales Market Share by Application (2013-2018)
11.2 Aspergillosis Sales Growth (2013-2018)
11.3 Dermatophytosis Sales Growth (2013-2018)
11.4 Candidiasis Sales Growth (2013-2018)
12 Antifungal Drug Market Forecast (2018-2023)
12.1 Global Antifungal Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Antifungal Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Antifungal Drug Market Forecast (2018-2023)
12.2.2 Europe Antifungal Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Antifungal Drug Market Forecast (2018-2023)
12.2.4 South America Antifungal Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Antifungal Drug Market Forecast (2018-2023)
12.3 Antifungal Drug Market Forecast by Type (2018-2023)
12.3.1 Global Antifungal Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Antifungal Drug Market Share Forecast by Type (2018-2023)
12.4 Antifungal Drug Market Forecast by Application (2018-2023)
12.4.1 Global Antifungal Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Antifungal Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Antifungal Drug Picture
Table Product Specifications of Antifungal Drug
Figure Global Sales Market Share of Antifungal Drug by Types in 2017
Table Antif
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
